Fundraising Fox
Nanoprox
1 known investors
Find your way into Nanoprox
Sign up to see every warm intro you have to Nanoprox
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanoprox team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NanoProX develops bismuth sulfide (Bi₂S₃) nanoparticles administered intravenously before radiotherapy to selectively accumulate in tumors and amplify local radiation dose, aiming to increase tumor cell elimination per session without new equipment. The company targets oncology treatment and works with research institutions and clinical centers on preclinical and clinical translation.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Nanoprox do?
- NanoProX develops bismuth sulfide (Bi₂S₃) nanoparticles administered intravenously before radiotherapy to selectively accumulate in tumors and amplify local radiation dose, aiming to increase tumor cell elimination per session without new equipment. The company targets oncology treatment and works with research institutions and clinical centers on preclinical and clinical translation.
- Who are Nanoprox's investors?
- Nanoprox's investors include GRIDX.